Super good news. CBIO just Granted Orphan Drug in Europe.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Recent CBIO News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:18:40 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:16:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:15:24 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 03/27/2026 08:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/17/2026 08:00:35 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 03/06/2026 09:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/04/2026 05:15:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/26/2026 02:04:21 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 12:32:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:30:15 PM
- Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/26/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:27:21 PM
- Crescent Biopharma to Present at March Investor Conferences • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 02/19/2026 12:30:00 PM
- Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors • GlobeNewswire Inc. • 02/18/2026 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 • GlobeNewswire Inc. • 02/05/2026 12:30:00 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 01/30/2026 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/15/2026 10:04:57 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/07/2026 10:08:21 PM
- Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 12/18/2025 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 09:49:10 PM
